Pharmaceutical company MSD Ireland, which is part of the US giant Merck, is planning to build a new €140 million manufacturing facility, [3,266sqm in size and 20.75m high] alongside their successful existing plant in Ballydine, Co. Tipperary.
Planning documents are understood to have been submitted to Tipperary County Council with the proposed scheme, same expected to create some 300 construction jobs over the life of the construction period, understood to take 18 months.
MSD, which employs some 2,700 people in the Irish Republic, said the proposed facility was needed to address a manufacturing need to produce small volume, highly effective drugs, to meet increasing product demands. An example of these types of medicines are those used for chemotherapy products.
The Ballydine site first opened in 1976 and currently employs some 500 highly skilled individuals. The site has API and Formulation facilities for the manufacture of commercial products and the development of new products.
They invested €75 million between 2014 and 2017, furthering their commitment to the manufacturing site with 20 of MSD’s pipeline products undertaken at this state-of-the-art research and commercialisation facility; exporting products to approximately 25 countries around the world for further processing.
Leave a Reply